Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial

• Main Authors: Jafar, T.H, Tan, N.C, Allen, J.C, Finkelstein, E.A, Goh, P, Moey, P, Quah, J.H.M, Hwang, S.W, Bahadin, J, Thiagarajah, A.G, Chan, J, Kang, G, Koong, A
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: angiotensin receptor antagonist; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; hydroxymethylglutaryl coenzyme A reductase inhibitor; thiazide diuretic agent; adult; Article; cardiovascular disease; controlled study; cost effectiveness analysis; disability-adjusted life year; drug cost; drug dose increase; drug dose titration; follow up; Framingham risk score; human; hypertension; medication compliance; motivation; multicenter study; multicenter study (topic); patient compliance; pilot study; primary medical care; quality adjusted life year; randomized controlled trial; randomized controlled trial (topic); Singapore; systolic blood pressure; cost benefit analysis; counseling; outcome assessment; risk factor; sample size; Adult; Cost-Benefit Analysis; Counseling; Humans; Hypertension; Motivation; Outcome Assessment (Health Care); Risk Factors; Sample Size
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178099
• Institution: National University of Singapore

10.1186/s13063-018-2559-x